Chapters in this book

1. Frontmatter i
2. Contents vii
3. Tables and Figures ix
4. Acknowledgments xi
5. 1. Putting the FDA into Perspective 1
6. 2. The Politics of Assessing Drugs 21
7. 3. An Evolving Regulatory Balance 49
8. 4. The Drug Lag Debate and Demands for Reform 75
9. 5. A Grand Compromise and the Shift to a New Era 95
10. 6. Whither the FDA? 119
11. 7. Protecting and Promoting Public Health in the United States 151
12. Appendix: Drug Development and the FDA’s Approval Process 165
13. List of Abbreviations 173
14. Notes 175
15. Bibliography 185
16. Index 203
17. About the Book 211